IL-17A Promotes Epithelial ADAM9 Expression in Cigarette Smoke-Related COPD

References

• Christenson SA, Smith BM, Bafadhel M, Putcha N. Chronic obstructive pulmonary disease. Lancet. 2022;399(10342):2227–2242. doi:10.1016/S0140-6736(22)00470-6
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27. doi:10.1016/j.jaci.2016.05.011
   PubMed Web of Science ®Google Scholar
• Owen CA. Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2008;3(2):253–268. doi:10.2147/copd.s2089
   PubMedGoogle Scholar
• Oreo KM, Gibson PG, Simpson JL, Wood LG, McDonald VM, Baines KJ. Sputum ADAM8 expression is increased in severe asthma and COPD. Clin Exp Allergy. 2014;44(3):342–352. doi:10.1111/cea.12223
   PubMed Web of Science ®Google Scholar
• Wang X, Polverino F, Rojas-Quintero J, et al. A disintegrin and a metalloproteinase-9 (ADAM9): a novel proteinase culprit with multifarious contributions to COPD. Am J Respir Crit Care Med. 2018;198(12):1500–1518. doi:10.1164/rccm.201711-2300OC
   PubMed Web of Science ®Google Scholar
• Cui L, Li H, Xie M, et al. Relationship between proteinase with a disintegrin and a metalloproteinase domain-9 (ADAM9), inflammation, airway remodeling, and emphysema in COPD patients. Int J Chron Obstruct Pulmon Dis. 2020;15:3335–3346. doi:10.2147/COPD.S276171
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang D, Higham A, et al. ADAM15 expression is increased in lung CD8(+) T cells, macrophages, and bronchial epithelial cells in patients with COPD and is inversely related to airflow obstruction. Respir Res. 2020;21(1):188. doi:10.1186/s12931-020-01446-5
   PubMed Web of Science ®Google Scholar
• Fachri M, Hatta M, Massi MN, et al. The strong correlation between ADAM33 expression and airway inflammation in chronic obstructive pulmonary disease and candidate for biomarker and treatment of COPD. Sci Rep. 2021;11(1):23162. doi:10.1038/s41598-021-02615-2
   PubMed Web of Science ®Google Scholar
• Seals DF, Courtneidge SA. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 2003;17(1):7–30. doi:10.1101/gad.1039703
   PubMed Web of Science ®Google Scholar
• Chou CW, Huang YK, Kuo TT, Liu JP, Sher YP. An overview of ADAM9: structure, activation, and regulation in human diseases. Int J Mol Sci. 2020;21(20):7790. doi:10.3390/ijms21207790
   PubMed Web of Science ®Google Scholar
• Lin CY, Chen HJ, Huang CC, et al. ADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathway. Cancer Res. 2014;74(18):5229–5243. doi:10.1158/0008-5472.CAN-13-2995
   PubMed Web of Science ®Google Scholar
• Roychaudhuri R, Hergrueter AH, Polverino F, et al. ADAM9 is a novel product of polymorphonuclear neutrophils: regulation of expression and contributions to extracellular matrix protein degradation during acute lung injury. J Immunol. 2014;193(5):2469–2482. doi:10.4049/jimmunol.1303370
   PubMed Web of Science ®Google Scholar
• Le Rouzic O, Pichavant M, Frealle E, Guillon A, Si-Tahar M, Gosset P. Th17 cytokines: novel potential therapeutic targets for COPD pathogenesis and exacerbations. Eur Respir J. 2017;50(4):1602434. doi:10.1183/13993003.02434-2016
   PubMed Web of Science ®Google Scholar
• Roos AB, Sandén C, Mori M, Bjermer L, Stampfli MR, Erjefält JS. IL-17A is elevated in end-stage chronic obstructive pulmonary disease and contributes to cigarette smoke-induced lymphoid neogenesis. Am J Respir Crit Care Med. 2015;191(11):1232–1241. doi:10.1164/rccm.201410-1861OC
   PubMed Web of Science ®Google Scholar
• Xiong J, Zhou L, Tian J, et al. Cigarette smoke-induced lymphoid neogenesis in COPD involves IL-17/RANKL pathway. Front Immunol. 2020;11:588522. doi:10.3389/fimmu.2020.588522
   PubMed Web of Science ®Google Scholar
• Kurimoto E, Miyahara N, Kanehiro A, et al. IL-17A is essential to the development of elastase-induced pulmonary inflammation and emphysema in mice. Respir Res. 2013;14(1):5. doi:10.1186/1465-9921-14-5
   PubMed Web of Science ®Google Scholar
• Chang Y, Al-Alwan L, Audusseau S, et al. Genetic deletion of IL-17A reduces cigarette smoke-induced inflammation and alveolar type II cell apoptosis. Am J Physiol Lung Cell Mol Physiol. 2014;306(2):132–143. doi:10.1152/ajplung.00111.2013
   Web of Science ®Google Scholar
• Roos AB, Sethi S, Nikota J, et al. IL-17A and the promotion of neutrophilia in acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(4):428–437. doi:10.1164/rccm.201409-1689OC
   PubMed Web of Science ®Google Scholar
• Bozinovski S, Seow HJ, Chan SP, et al. Innate cellular sources of interleukin-17A regulate macrophage accumulation in cigarette- smoke-induced lung inflammation in mice. Clin Sci (Lond). 2015;129(9):785–796. doi:10.1042/CS20140703
   PubMed Web of Science ®Google Scholar
• Chen K, Pociask DA, McAleer JP, et al. IL-17RA is required for CCL2 expression, macrophage recruitment, and emphysema in response to cigarette smoke. PLoS One. 2011;6(5):e20333. doi:10.1371/journal.pone.0020333
   PubMed Web of Science ®Google Scholar
• Baggio C, Velazquez JV, Fragai M, Nordgren TM, Pellecchia M. Therapeutic targeting of MMP-12 for the treatment of chronic obstructive pulmonary disease. J Med Chem. 2020;63(21):12911–12920. doi:10.1021/acs.jmedchem.0c01285
   PubMed Web of Science ®Google Scholar
• Prause O, Bozinovski S, Anderson GP, Lindén A. Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways. Thorax. 2004;59(4):313–317. doi:10.1136/thx.2003.008854
   PubMed Web of Science ®Google Scholar
• Ding F, Han L, Fu Q, et al. IL-17 aggravates pseudomonas aeruginosa airway infection in acute exacerbations of chronic obstructive pulmonary disease. Front Immunol. 2021;12:811803. doi:10.3389/fimmu.2021.811803
   PubMed Web of Science ®Google Scholar
• Zhou L, Le Y, Tian J, et al. Cigarette smoke-induced RANKL expression enhances MMP-9 production by alveolar macrophages. Int J Chron Obstruct Pulmon Dis. 2019;14:81–91. doi:10.2147/COPD.S190023
   PubMed Web of Science ®Google Scholar
• Xiong J, Le Y, Rao Y, et al. RANKL mediates muscle atrophy and dysfunction in a cigarette smoke-induced model of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2021;64(5):617–628. doi:10.1165/rcmb.2020-0449OC
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhao Y, Zhou H, et al. Autophagy plays an essential role in cigarette smoke-induced expression of MUC5AC in airway epithelium. Am J Physiol Lung Cell Mol Physiol. 2016;310(11):1042–1052. doi:10.1152/ajplung.00418.2015
   Web of Science ®Google Scholar
• Eurlings IM, Reynaert NL, van de Wetering C, et al. Involvement of c-Jun N-terminal kinase in TNF-α-driven remodeling. Am J Respir Cell Mol Biol. 2017;56(3):393–401. doi:10.1165/rcmb.2015-0195OC
   PubMed Web of Science ®Google Scholar
• Wagner C, Uliczka K, Bossen J, et al. Constitutive immune activity promotes JNK- and FoxO-dependent remodeling of drosophila airways. Cell Rep. 2021;35(1):108956. doi:10.1016/j.celrep.2021.108956
   PubMed Web of Science ®Google Scholar
• Turino GM. The origins of a concept: the protease-antiprotease imbalance hypothesis. Chest. 2002;122(3):1058–1060. doi:10.1378/chest.122.3.1058
   PubMed Web of Science ®Google Scholar
• Eustace A, Smyth LJC, Mitchell L, Williamson K, Plumb J, Singh D. Identification of cells expressing IL-17A and IL-17F in the lungs of patients with COPD. Chest. 2011;139(5):1089–1100. doi:10.1378/chest.10-0779
   PubMed Web of Science ®Google Scholar
• Montalbano AM, Riccobono L, Siena L, et al. Cigarette smoke affects IL-17A, IL-17F and IL-17 receptor expression in the lung tissue: ex vivo and in vitro studies. Cytokine. 2015;76(2):391–402. doi:10.1016/j.cyto.2015.07.013
   PubMed Web of Science ®Google Scholar
• Chang Y, Nadigel J, Boulais N, et al. CD8 positive T cells express IL-17 in patients with chronic obstructive pulmonary disease. Respir Res. 2011;12(1):43. doi:10.1186/1465-9921-12-43
   PubMed Web of Science ®Google Scholar
• Chang Y, Al-Alwan L, Alshakfa S, et al. Upregulation of IL-17A/F from human lung tissue explants with cigarette smoke exposure: implications for COPD. Respir Res. 2014;15(1):145. doi:10.1186/s12931-014-0145-7
   PubMed Web of Science ®Google Scholar
• Chu S, Zhong X, Zhang J, Lao Q, He Z, Bai J. The expression of Foxp3 and ROR gamma t in lung tissues from normal smokers and chronic obstructive pulmonary disease patients. Int Immunopharmacol. 2011;11(11):1780–1788. doi:10.1016/j.intimp.2011.06.010
   PubMed Web of Science ®Google Scholar
• Wu M, Lai T, Jing D, et al. Epithelium-derived IL17A promotes cigarette smoke-induced inflammation and mucus hyperproduction. Am J Respir Cell Mol Biol. 2021;65(6):581–592. doi:10.1165/rcmb.2020-0424OC
   PubMed Web of Science ®Google Scholar
• Li S, Cong X, Gao H, et al. Tumor-associated neutrophils induce EMT by IL-17a to promote migration and invasion in gastric cancer cells. J Exp Clin Cancer Res. 2019;38(1):6. doi:10.1186/s13046-018-1003-0
   PubMed Web of Science ®Google Scholar
• van Kampen JGM, van Hooij O, Jansen CF, et al. MiRNA-520f reverses epithelial-to-mesenchymal transition by targeting ADAM9 and TGFBR2. Cancer Res. 2017;77(8):2008–2017. doi:10.1158/0008-5472.CAN-16-2609
   PubMed Web of Science ®Google Scholar
• Ma L, Jiang M, Zhao X, Sun J, Pan Q, Chu S. Cigarette and IL-17A synergistically induce bronchial epithelial-mesenchymal transition via activating IL-17R/NF-κB signaling. BMC Pulm Med. 2020;20(1):26. doi:10.1186/s12890-020-1057-6
   PubMed Web of Science ®Google Scholar
• Chu S, Ma L, Wu Y, Zhao X, Xiao B, Pan Q. C-EBPβ mediates in cigarette/IL-17A-induced bronchial epithelial-mesenchymal transition in COPD mice. BMC Pulm Med. 2021;21(1):376. doi:10.1186/s12890-021-01738-6
   PubMed Web of Science ®Google Scholar
• Umeda M, Yoshida N, Hisada R, et al. ADAM9 enhances Th17 cell differentiation and autoimmunity by activating TGF-β1. Proc Natl Acad Sci U S A. 2021;118:18. doi:10.1073/pnas.2023230118
   Web of Science ®Google Scholar